Crohn’s disease
Adalimumab and Infliximab.
Off
NICE appraisal
(May 2010)
DSU reports
DSU response to comments on DSU Crohn’s Report 2 (PDF, 85KB) (August 2009)
Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease – Report 2 (PDF, 372KB) (June 2009)
Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease (PDF, 61KB) (January 2009)